Market Value760,541,000
Total Holdings50
File Date2019-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
IWM / iShares Trust - iShares Russell 2000 ETF Put
VCEL / Vericel Corporation
SPY / SPDR S&P 500 ETF Put
HZNP / Horizon Therapeutics Plc
TSRO / TESARO, Inc.
INCY / Incyte Corporation
71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
DOVA / Dova Pharmaceuticals, Inc.
US64052L1061 / Neos Therapeutics, Inc.
OPTN / OptiNose, Inc.
TNDM / Tandem Diabetes Care, Inc.
TSRO / TESARO, Inc. Call
GBT / Global Blood Therapeutics Inc. Call
OMED / OptMed Inc
CORI / Corium International, Inc.
ANGO / AngioDynamics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
XENE / Xenon Pharmaceuticals Inc.
NVLN / NOVELION THERAPEUTICS INC.
PACB / Pacific Biosciences of California, Inc.
SRRA / Sierra Oncology Inc
IDRA / Idera Pharmaceuticals, Inc.
IART / Integra LifeSciences Holdings Corporation
NVRO / Nevro Corp. Call
KALV / KalVista Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
XENT / Intersect ENT Inc
EIGR / Eiger BioPharmaceuticals, Inc.
NSTG / NanoString Technologies, Inc.
REPH / Societal CDMO Inc
LJPC / La Jolla Pharmaceutical Co.
LJPC / La Jolla Pharmaceutical Co. Call
ZGNX / Zogenix Inc
ADMS / Adamas Pharmaceuticals Inc
OSMT / Osmotica Pharmaceuticals Plc
DXCM / DexCom, Inc.
KALA / KALA BIO, Inc.
ADMA / ADMA Biologics, Inc.
PETX / Aratana Therapeutics, Inc.
TLGT / Teligent Inc
ATRS / Antares Pharma Inc
TVTX / Travere Therapeutics, Inc.
SLGL / Sol-Gel Technologies Ltd.
GBT / Global Blood Therapeutics Inc.
HRTX / Heron Therapeutics, Inc. Call
LIVN / LivaNova PLC
SSKN / STRATA Skin Sciences, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call
US0153511094 / Alexion Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
SBBP / Strongbridge Biopharma plc
AVDL / Avadel Pharmaceuticals plc
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
QTNT / Quotient Ltd
HRTX / Heron Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ATEC / Alphatec Holdings, Inc.
BDSI / Biodelivery Sciences International
NVRO / Nevro Corp.
CPRX / Catalyst Pharmaceuticals, Inc.
VRAY / ViewRay Inc.
SCYX / SCYNEXIS, Inc.
IOVA / Iovance Biotherapeutics, Inc.